EGFR and lung carcinoma: Study of Cul4A in NSCLS shows that Cul4A overexpression promotes docetaxel and doxorubicin resistance in lung cancer cells, it may attribute to EGFR transcriptional expression and antiapoptosis of NSCLC cells regulated by Cul4A10.